Skip to main content

Peer Review reports

From: Efficacy and safety of azvudine in symptomatic adult COVID-19 participants who are at increased risk of progressing to critical illness: a study protocol for a multicentre randomized double-blind placebo-controlled phase III trial

Original Submission
22 Sep 2023 Submitted Original manuscript
13 Oct 2023 Reviewed Reviewer Report - Rareș Mișcov
13 Oct 2023 Reviewed Reviewer Report - Shriya Das
16 Oct 2023 Reviewed Reviewer Report - Research Square Reviewer 1
16 Oct 2023 Reviewed Reviewer Report - Sheryl Abdukahil
17 Oct 2023 Reviewed Reviewer Report - Mehrnaz Abbasi
21 Oct 2023 Reviewed Reviewer Report - Herman Lule
25 Oct 2023 Reviewed Reviewer Report - Onome Abiri
13 Nov 2023 Author responded Author comments - Xinlun Tian
Resubmission - Version 2
13 Nov 2023 Submitted Manuscript version 2
19 Nov 2023 Reviewed Reviewer Report - Herman Lule
19 Nov 2023 Reviewed Reviewer Report - Shriya Das
20 Nov 2023 Reviewed Reviewer Report - Alexander Gough
20 Nov 2023 Reviewed Reviewer Report - Onome Abiri
20 Nov 2023 Reviewed Reviewer Report - Rareș Mișcov
21 Nov 2023 Reviewed Reviewer Report - Sheryl Abdukahil
16 Dec 2023 Author responded Author comments - Xinlun Tian
Resubmission - Version 3
16 Dec 2023 Submitted Manuscript version 3
19 Dec 2023 Reviewed Reviewer Report - Sheryl Abdukahil
27 Dec 2023 Reviewed Reviewer Report - Shriya Das
1 Jan 2024 Reviewed Reviewer Report - Herman Lule
2 Jan 2024 Reviewed Reviewer Report - Alexander Gough
6 Jan 2024 Reviewed Reviewer Report - Onome Abiri
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
8 Jan 2024 Editorially accepted
22 Jan 2024 Article published 10.1186/s13063-024-07914-3

You can find further information about peer review here.

Back to article page